In vivo and in vitro complex formation of prostate specific antigen with αi‐anti‐chymotrypsin

The Prostate

Volumn 27, Issue 3, 1995, Pages 166-175

  Huber, Peter R ^a   Mattarelli, Gianfranco ^b   Strittmatter, Bernadette ^a   van Steenbrugge, Gert Jan ^d   Schmid, Hans‐Peter ^b   Maurer, Andreas ^c  

^a Kantonsspital Basel   (Switzerland)

^b Division of Urology   (Switzerland)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

alpha 1 anti chymotrypsin; complex formation; prostate specific antigen; PSA

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; PROSTATE SPECIFIC ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; COMPUTER ASSISTED THERAPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTHERMIC THERAPY; IMMUNOASSAY; MALE; MICROWAVE IRRADIATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; TUMOR CELL LINE;

ALPHA 1-ANTICHYMOTRYPSIN; ANIMAL; CHROMATOGRAPHY, GEL; COMPARATIVE STUDY; HUMAN; HYPERTHERMIA, INDUCED; IMMUNOENZYME TECHNIQUES; IN VITRO; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RADIOIMMUNOASSAY; SERINE PROTEINASE INHIBITORS; TUMOR CELLS, CULTURED;

EID: 0029051720     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.2990270308     Document Type: Article

References (26)

1. A Kallikrein‐like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein
2. Seminal vesicle secreted proteins and their reactions during gelation and liquefaction of human semen
3. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate II. Radical prostatectomy treated patients
4. Detection of prostate cancer in males with prostatism
5. Ultrasensitive time‐resolved immunofluorometric assay of prostate‐specific antigen in serum and preliminary clinical studies
6. Prostate‐specific antigen: Problems in analysis
7. A comparison of 4 ultrasensitive prostate specific antigen assays for early detection of residual cancer after radical prostatectomy
8. A complex between prostate‐specific antigen and α1‐antichymotrypsin is the major form of prostate‐specific antigen in serum of patients with prostate cancer: Assay of the complex improves clinical sensitivity for cancer
9. Multiple forms of prostate‐specific antigen in immunorecognition by monoclonal and polyclonal assays
10. Prostate‐specific antigen in serum occurs predominantly in complex with α1‐antichymotrypsin
11. Prostate‐specific antigen predominantly forms a complex with α1‐antichymotrypsin in blood
12. Enzymatic activity of prostate‐specific antigen and its reaction with extracellular serine protease inhibitors
13. Double‐label time resolved immunofluorometric assay of prostate‐specific antigen and of its complex with α1‐antichymotrypsin
14. A prostate antigen in sera of prostatic cancer patients
15. Circulating antibody to prostate specific antigen in patients with prostate cancer
16. The establishment and evaluation of luminescent‐labelled immunometric assays for prostate specific antigen‐α1‐antichymotrypsin complexes in serum
17. PSA‐α1‐antichymotrypsin determination in patients with benign prostatic hyperplasia and prostatic cancer
18. Single session transurethral microwave thermotherapy for the treatment of benign prostatic obstruction
19. The LNCAP cell line—a new model for studies on human prostate carcinoma
20. LNCAP model of human prostatic carcinoma
21. Permanent propagation of the human prostatic carcinoma cell line LNCAP in athymic nude mice
22. Effect of culture conditions on androgen sensitivity of the human prostatic cancer cell line LNCAP
23. Sind die Marker PAP und PSA bei der Planung einer radikalen Prostaktomie aussagekräftig
24. Production of α1‐antichymotrypsin by PSA‐containing cells of human prostate epithelium